This compound is a protected nucleoside intermediate used in the synthesis of oligonucleotides. Its structure features a bicyclic sugar moiety and a benzamide-protected pyrimidine base, making it suitable for solid-phase or solution-phase oligonucleotide assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 445012-77-1
N6-BENZOYL-2'-O-METHYL-ADENOSINE
pharmaceutical intermediate
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide
pharmaceutical intermediate
N-Acetyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-methylcytidine
pharmaceutical intermediate
2-Methoxyl-5-pyridineboronic acid pinacol ester
pharmaceutical intermediate
3,4-dihydro-2-methoxy-2H-pyran
pharmaceutical intermediate
Ethyl (methylthio)acetate
pharmaceutical intermediate
4-Nitrobenzyl chloroformate
pharmaceutical intermediate
(1R,3R,4R,7S)-3-(4-N-Benzoyl-5-methylcytosin-1-yl)-7-(2-cyanoethoxy(diisopropylamino)phosphinoxy)-1-(4,4'-dimethoxytrityloxymethyl)-2,5-dioxabicyclo(2.2.1)heptane
pharmaceutical intermediate
N-[1-[(1R,3R,4R,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
CTGWFRQUULNNIN-OSZGUBSQSA-N
CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)[C@H]3[C@H]4[C@@H]([C@@](O3)(CO4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)O
—